Serum Level of Antibody against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in People Dermally Exposed to PAHs

Table 1

The serum level of anti-BPDE-DNA before and after the therapy (all patients).

CCT content	Anti-BPDE-DNA		Statistical significance of differences
	Before GT	After GT
CCT-3% (𝑛=23)	0.22 (0.18–0.29)	0.28 (0.20–0.34)	𝑃<𝟎.𝟎𝟏
CCT-5% (𝑛=32)	0.31 (0.25–0.45)	0.37 (0.28–0.48)	𝑃<𝟎.𝟎𝟎𝟏
Statistical significance of differences	𝑃<𝟎.𝟎𝟏	𝑃<𝟎.𝟎𝟓

Anti-BPDE-DNA values (expressed as the EI) are presented as median (lower–upper quartile) because of nonnormal data distribution; 𝑛: number of subjects; 𝑃: Wilcoxon matched-pairs test.